Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study

By Burgess M.A.   Rodger A.J.   Waite S.A.   Collard F.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4835-4841

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system

By Thoelen S.   Van Damme P.   Mathei C.   Leroux-Roels G.   Desombere I.   Safary A.   Vandepapeliere P.   Slaoui M.   Meheus A.  

Vaccine, Vol. 16, Iss. 7, 1998-04 ,pp. : 708-714

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in children

By Raz R.   Dagan R.   Gallil A.   Brill G.   Kassis I.   Koren R.  

Vaccine, Vol. 14, Iss. 3, 1996-02 ,pp. : 207-211

Elsevier

Access to resources Recommend Favorite

Immune response to an indigenously developed hepatitis-B (Shanvac-B) vaccine in a tribal community of India

By Murhekar M.V.   Murhekar K.M.   Arankalle V.A.   Sehgal S.C.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3431-3435

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine

By Dagan R.   Greenberg D.   Goldenbertg-Gehtman P.   Vidor E.   Briantais P.   Pinsk V.   Athias O.   Dumas R.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1919-1925

Elsevier

Access to resources Recommend Favorite